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lycemic index (GI) is currently con-
sidered as an alternative system that 
classifies food according to the carbo-
hydrate quality (CHO), measuring its absorption speed; 
meanwhile, glycemic load GL is a more recent term 
that relates the quality and quantity of the CHO per 
gram of the usual consumption portion. Glycemic in-
dex and glycemic load reduce the post-prandial glyce-
mic impact without the total restriction of CHO in the 
diet. Initially, GI was used only in patients with diabetes, 
currently it is also considered as a risk indicator in 
other pathologies. However, there is great controversy 
due to an inaccurate interpretation of the knowledge 
about the methodology used for its determination. 
The aim of this review is to elucidate this current 
debate and to expand the relationship between the GI 
and the risk of diabetes and other chronic diseases; 
thus, highlighting new prospects for its applicability in 
the dietary intervention for diabetic athletes and in the 
production of functional food designed for patients with 
diabetes. There is strong evidence that this indicator 
has become an innovative system for various multi-
disciplinary health programs.
Key words: glycemic index, diabetes, chronic diseas-
es, functional food.
ctualmente el índice glicémico (IG) 
se considera como un sistema al-
ternativo que clasifica los alimentos 
según la calidad de los carbohidratos (CHO), midiendo 
su velocidad de absorción; por otra parte, la carga gli-
cémica (CG) es un término más reciente que relaciona 
la calidad y la cantidad de CHO por gramo de la porción 
de consumo habitual. El índice glcémico y la carga glu-
cémica reducen el impacto glicémico posprandial sin la 
restricción total de CHO en la dieta. Inicialmente, el IG 
era utilizado solo en pacientes diabéticos, actualmente 
también se considera un indicador de riesgo en otras 
patologías. Sin embargo, existe una gran controversia 
debido a una interpretación incorrecta del conocimiento 
sobre la metodología utilizada para su determinación. El 
objetivo de esta revisión es dilucidar este debate actual 
y ampliar la relación entre el IG y el riesgo de diabetes 
y otras enfermedades crónicas; así, se destacan nue-
vas perspectivas de su aplicabilidad en la intervención 
dietética para deportistas diabéticos y en la producción 
de alimentos funcionales diseñados para pacientes con 
diabetes. Existen fuertes evidencias de que este indi-
cador se ha convertido en un sistema innovador para 
varios programas de salud multidisciplinarios.
Palabras claves: Índice glicémico, diabetes, enferme-
dad crónica, alimentos funcionale
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he glycemic index (GI) is an alternative sys-
tem that allows the numerical expression of 
available carbohydrates effect of a food on 
glucose concentrations1, representing a measure of 
the average glycemic value following the ingestion of 
a food, usually 50 g of carbohydrates available for a 
given period of time of 2 or 3 hours2,3 expressed as a 
percentage in relation to a standard food (glucose or 
white bread). Glucose is considered a reference prod-
uct with an attributed GI of 1004,5. By replacing a high 
GI food with a lower GI food a decrease in glycemia is 
generated, providing a way to express the potential 
glycemic effect of a meal or snack. Foods with car-
bohydrates capable of being digested, absorbed and 
metabolized rapidly are considered of high GI ≥70 on 
the glucose scale. Those between 55-70 are consid-
ered of intermediate GI, while those with low GI cor-
respond to a value ≤55. The glycemic load (GL) is the 
result of the GI and the total amount of carbohydrate 
available according to a specific portion of food1,6. In 
this sense, the GI classifies the foods according to the 
quality of carbohydrates (CHO), measuring their speed 
of absorption; In terms of GL is a more recent term that 
relates quality and quantity of CHO per grams of usual 
consumption portion.
Both indicators allow reducing the postprandial glyce-
mic impact without the total restriction of CHO in the 
diet. The GI tables for food were developed in 1995 
and later updated in 2002 and 20081,7. There is a great 
controversy due to an inaccurate interpretation of the 
tests to determine the GI, being the objective of this 
review to elucidate the reasons that explain this current 
debate, to extend the relation between the GI and the 
risk of new chronic diseases and to highlight the novel 
perspectives of its applicability in physical exercise and 
in the food industry.
bibliographic search was per-
formed to retrieve relevant articles 
published from 5 February to May 
2018 from scientific searchers (PUBMED, EBSCO, 
Scielo and Scopus) to analyze articles that included 
keywords (glycemic index / glycemic load / risk / diabe-
tes / obesity / cancer / renal / epilepsy / physical activ-
ity / functional products). Four researchers in English 
and Spanish performed manual review of the articles.
Randomized studies, control cases, and intervention 
studies were included in the search for articles that 
make up this review. Evidence indicates that the use-
fulness of GI values for managing chronic disease risk 
remains controversial. Wolever TM, one of the creators 
of this system, claims to be as reliable as the value 
of macronutrients in food labels8. Despite its controver-
sial use, this indicator has been included in the guide-
lines of dietary recommendations for the population in 
Nordic countries9 and Italy10. Even though most of the 
world’s dietary associations have not considered this 
tool among their nutritional guidelines, the European 
Association for the Study of Diabetes, the American 
Diabetes Association, the Canadian Diabetes Associa-
tion and the Diabetes Nutrition Subcommittee of the 
UK have rated CHO quality management as a priority 
within their recommendations11,12,13,14. Specifically, 
the International Diabetes Federation recognized the 
relevance of post-prandial glucose regulation for 
achieving glycosylated hemoglobin (HbA1c) targets 
through the development of specific guidelines, the 
management of which is linked to the concept of GI15.
Controversy on the methodology
Most current criticisms point to high glycemic vari-
ability in healthy adults. In this regard, a study with 63 
healthy subjects examined intra and interindividual vari-
ability (CV) in the glycemic response, as well as meth-
odological and biological factors that potentially mediate 
this response. CV was 20% and 25%, respectively.
Among the biological factors evaluated, the insulin in-
dex and the HbA1c values explained 15% and 16% of 
the variability in the mean value of GI for white bread, 
concluding that there is a high variability in the individual 
response to the determination of the value of GI. This 
group of authors classifies GI as an inappropriate ap-
proach to guide food selection16. Recent reviews have 
been based on concerns about the validity of this 
indicator, in the hypothesis that it cannot predict the 
glycemic response, or about the alleged imprecision of 
the methodology2,17, in addition to that it is not possible 
to estimate the value of the GI in mixed meals18,19, and 
that many factors influence the results. In response to 
these premises, the last consensus of experts in GI1, 
concluded that most of the current criticisms are not 
valid, reflecting a failure in the translation of knowl-
edge6,20. Some premises, for example the GI of the 
subjects change daily, are based on the misuse of the 
term “GI” as if it were synonymous with “glycemic re-
sponse” (GR). “GI” is not “GR” and therefore care must 
be taken to use the terms correctly.
The initial central methodology used to measure GI has 
not changed, therefore to improve accuracy, a series 
of procedures were modified3. If the GI is method-
ologically correctly used, it is sufficiently accurate to 
distinguish between high GI (HGI 70) and low GI (LGI 
55) foods on the glucose scale with 95% certainty6. 
Alternative terms include “GR” or “Relative GR”. It 
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is not necessarily expected that the calculated GI of 
mixed foods will predict their glycemic response, since 
the glycemic impact of these foods depends not only on 
their GI, but also on the amounts and types of lipids, 
proteins and CHO contained in the diet. On the other 
hand, the GI is a property of foods rich in CHO, so 
it is not appropriate to measure this indicator in this 
type of food. In these cases, this value must be 
determined from the GI of the carbohydrates, foods or 
ingredients in the food and calculated in the same way 
as the GI average of a diet is quantified6. A number of 
critics have raised the objection that many factors, such 
as variety, processing and cooking, influence the GI of 
a food. In fact, these factors affect it but this is not an 
argument against the use of this indicator; rather it is 
a cause that is useful as another tool to quantify the 
impact, as postprandial glycemia serves as an indicator 
of risks in various pathologies1.
Glycemic index as a risk marker of diseases
There is strong evidence of the relevance of GI in some 
diseases such as diabetes21 cardiovascular diseas-
es22, cancer and even for body weight control1..
These trends were confirmed recently in men and 
women, with greater risk reduction in the latter23. Re-
duced risk of coronary heart disease, as well as the risk 
of certain types of cancer, mainly breast and colorec-
tal, have been demonstrated with low GL and GI diets 
in women, although not all studies have shown these 
benefits26,27,28. There are investigations that relate the 
modification of risk factors for these diseases together 
with the GI of the diet1. Studies from a large meta-
analysis have shown that low-GI diets significantly im-
proved glycemic control23 and LDL-cholesterol29, even 
though there are not many studies with proven changes 
in HbA1c, some clinical trials have shown significant 
decrease in C- reactive protein30,31,32. Another review 
identified a total of 37 prospective cohort studies of GI, 
GL and risk of chronic disease. Low GI and / or low GL 
diets are independently associated with a reduced risk 
of certain chronic diseases. In diabetes and cardiovas-
cular disease, protection is comparable to that observed 
for fiber intake.
The findings support the hypothesis that increased 
postprandial glycaemia is a universal mechanism for 
the progression of the disease33.
Type I and Type 2 Diabetes
Despite the difference in glycemic curve stability in 
subjects with diabetes type 2 (DM2) compared to 
healthy subjects, several studies have indicated the as-
sociation between nutritional status and glycemic vari-
ability in individuals with this pathology34,35,36. However, 
few well-controlled investigations have exhaustively ex-
amined the effects of very low carbohydrate diets on 
this condition.
In a meta-analysis, 10 randomized trials were consid-
ered in 1376 participants comparing diets containing 
low to moderate amounts of CHO (<45% energy) v/s 
diets containing high amounts of this nutrient in subjects 
with DM2. The greater the restriction of carbohydrates, 
greater the effect of the decrease in glucose (R=-
0.85, p<0.01). However, HbA1c was similar in the sec-
ond group of dietary intervention post-1-year, conclud-
ing that low to moderate carbohydrate diets have a 
greater effect on glycemic control. In addition to this 
decrease HbA1c in short-term, there is no superiority 
of carbohydrate-restricted diets in terms of glycemic, 
weight or LDL cholesterol control37. In another report 
of multivariable regression analysis in a cohort of 3918 
Chinese adults, was correlated the GI, GL and glyce-
mic homeostasis and evaluated the hypothesis that 
these associations may be modified by their genetic 
predisposition or if there are any combined effects with 
the intake of dietary fiber present in cereals. This rela-
tionship was more pronounced among people with a 
high genetic risk of DM2 or with a low intake of cereal 
fiber, evidencing that these indicators exert relevance in 
the glycemic homeostasis of this population, particu-
larly among the individuals genetically predisposed to 
DM238. In a cross-sectional study of 640 patients with 
DM2, associations of GI, GL, intake of CHO and fiber 
with hyperglycemia were investigated. The elevated 
GL of the diet was associated with an increased risk of 
this complication in these subjects. GI was not signifi-
cantly associated with elevated fasting plasmatic gly-
caemia (FPG) or HbA1c. The higher intake of dietary 
fiber was associated with a lower risk of increased FPG 
but not with a lower risk of HbA1c increased. GL and 
CHO intake were positively associated with the risk 
of hyperglycemia in type 2 diabetic patients. A meta-
analysis of prospective cohorts finding consistent with 
the protective effects of GI and dietary GL, quantifying 
the range of ingestion associated with a minor risk39.
Gestational Diabetes Mellitus
A study of 9 randomized controlled trials evaluated the 
effects on pregnancy of 11 types of dietary counseling 
for women with gestational diabetes mellitus (GDM); 
429 mothers and 436 infants, including high, low and 
moderate GI foods, high amounts of monounsaturated 
fats and fiber, were included compared to the standard 
recommended diet of ADA. No significant differences 
were observed in macrosomia for gestational age40. An-
other meta-analysis of 11 trials involving 1985 women 
and 11 newborns examined the maternal and neona-
tal effects of low GI diets comparing healthy pregnan-
cies and those diagnosed with GDM. In 8 trials, gesta-
tional weight gain, fasting blood glucose, birth weight, 
weight index, macrosomic ratio and gestational age 
were investigated (Big for gestational age, BGA). Low 
GI diets significantly reduced fasting and post-prandial 
glucose and BGA ratio41, concluding that low GI diets 
may have beneficial effects on maternal outcomes for 
those at risk of developing high glucose levels without 
causing adverse effects on newborn outcomes. An-
other study reported the comparison of the effects of 
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a general dietary intervention and another with low 
GL on glycemic and lipid control in pregnant women 
with GDM. The intensive intervention of low GL in two 
groups of mothers with 2 and 26 weeks of gestational 
age respectively.
Significantly decreased energy intake, lipid and car-
bohydrate consumption, without affecting body weight 
gain, birth weight or other maternal-fetal outcomes. Low 
GI dietary intervention outperformed the other inter-
vention in glycemic control and improved lipid levels in 
women with GDM42.
Dyslipidemias and heart diseases
In a random effects meta-analysis, twenty-eight tri-
als comparing low and high GI diets for 4 weeks in 
1272 participants, concluded that this type of diet re-
duces total and LDL cholesterol without affecting HDL 
cholesterol or triglycerides29. In a systematic review and 
meta-analysis of 14 randomized controlled trials, as-
sociations of GI and GL were determined with systolic 
blood pressure and diastolic blood pressure in 1097 
healthy subjects for 6 weeks, concluding that a lower 
GL diet can lead to significant reductions in blood pres-
sure. In another study of 44099 participants, the GI and 
GL variables of the diet were correlated with the risk 
of stroke in the large EPIC-Italy (EPICOR) cohort; 
associating significantly diets of high GI and high GL 
with the increased risk of stroke, both hemorrhagic 
and ischemic. Concluding that in this Italian cohort, the 
consumption of foods with high GI and GL increased 
the overall risk of stroke43.
GI and obesity
In a low-GI dietary intervention in 20 obese individuals, 
there was an increase in fat use during exercise, regard-
less of changes in energy expenditure, which highlights 
the therapeutic potential of low GI foods to reverse 
metabolic effects in obesity44.
Another controlled study with 19 subjects indicated that 
a low GI diet along with 12-week exercise would in-
crease the expression of fat transporters and oxida-
tion in skeletal muscle resistant to insulin, evidencing a 
weight loss of 8% to 10%, improvement in insulin sen-
sitivity and molecular mechanisms of skeletal muscle.
These effects were independent of the GI of the di-
ets45. In another study with 30 healthy controls, it was 
found that high GL food significantly increased blood 
glucose levels, especially in overweight individuals46. In 
a review discussion, several epidemiological and inter-
vention studies show an evident relationship between 
GL and the development of DM2, as well as GI on body 
weight, triacylglycerides, HDL-cholesterol, C-reactive 
protein (CRP) and protein glycation.
On the other hand, the beneficial effects of long-term 
interventions through the administration of low-GI / 
low-GL diets relative to basal insulin and CRP may be 
useful in the primary prevention of other obesity-associ-
ated diseases48,49.
GI in menopause and depression
Low circulating levels of sex hormone binding globulin 
(SHBG) have been shown to be a direct and strong 
risk factor for DM2, heart disease and hormone-de-
pendent neoplasms. In a study of 11,159 menopausal 
women in whom GL, GI, fiber, and high specific food 
intake were evaluated, low GL / GI diets with low sugar 
content and high fiber content were found to be associ-
ated with higher serum concentrations of SHBG levels 
among postmenopausal women50. In another prospec-
tive 3-year study of 69,954 postmenopausal women, 
depression, GI, GL and specific carbohydrate intake 
(added sugars, total sugars, glucose, sucrose, lactose, 
fructose and starch) were correlated, concluding that 
high GI diets could be a risk factor for depression in this 
population subgroup, suggesting randomized trials to 
determine whether low-GI diets could serve as preven-
tive treatments for depression in these women51.
Dietary glycemic index, glycemic load and cancer
A review demonstrated the association between GI and 
GL, with the risk of suffering from several types of neo-
plasia27, strongly evidencing the high GI of the diet with 
the risk of colorectal cancer, and high GL with breast 
and endometrial cancer27. Specifically, a relative risk of 
cancer was found with the following number of studies 
per organ with a 95% confidence interval: (19 breast, 
68 colorectal, 10 endometrium, 10 esophagus, 4 he-
patic, 4 ovary, 5 pancreas, 10 prostata, 6 stomach27).
It is believed that the main mechanism of these associa-
tions is chronic hyperinsulinemia52, 53,54. Insulin behaves 
like a mitogen and could also increase the bioactivity of 
insulin-like growth factors that can promote cancer by 
inhibiting apoptosis and stimulating cell proliferation. 
In a meta-analysis, six cohort studies and two case-
control studies, with a total of 5,569 cases including 
1,290 women with endometrial cancer and 1,436 con-
trols, a moderate positive association was observed 
between GI and risk of this type of cancer, but was not 
associated with elevated GL in the diet. The pooled 
results of the observational studies, including the con-
trol cases, provide evidence of a modest positive as-
sociation between high GL but not GI and the risk 
of this pathology55. In another meta-analysis of 10 
prospective studies of 15,839 cases and 577,538 par-
ticipants, the GI and GL were associated with the risk 
of breast cancer finding a relative risk with 95% confi-
dence intervals. These associations were modified by 
geographic region, follow-up period, number of cases 
or initial menopausal status, suggesting that high GI in 
the diet and not so the GL of the diet is associated 
with a significantly higher risk of breast cancer56.
Glycemic Index as Epilepsy Treatment
In a study of 36 patients with epilepsy who received 
low-GI dietary treatment for one year, the frequency of 
seizures was effectively reduced, although the freedom 
of episodes was only reduced by 2%, considering it 
as a therapeutic option for drug-resistant epileptic pa-
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tients57. Epilepsy is known to be a common feature of 
Angelman syndrome and seizures are often refractory 
to multiple medications.
Through a retrospective review of the medical record 
of 23 subjects who used this type of treatment at the 
Center for Dietetic Therapy of Epilepsy in Massachu-
setts and in another small trial published by Thibert, 
concluded that high seizure control and low-profile of 
secondary effects make the low GI diet an excellent al-
ternative to antiepileptic drug therapy in patients with 
this syndrome58. Another study with 42 children diag-
nosed with refractory epilepsy, they were given a diet 
consisting of 65% fat, 25% protein and 10% carbo-
hydrate (40-60 g) with a GI <50. A seizure reduction 
of more than 50% was observed in 71.4% patients 
after 15 days, in 73.8% and 77.8% at the end of the 
first and second month respectively, without signifi-
cant complications, therefore it is suggested as a safe 
adjuvant antiepileptic therapy as an alternative to the 
ketogenic diet in conditions in which it cannot be used, 
particularly in those who find this treatment effective 
but with a high degree of intolerance59.
Glycemic indicator and glycemic load of functional 
products for diabetics
Currently the food industry has created a large quantity 
of products with different bio-active components such 
as soluble fiber with a determined GI and GL. These 
products specialized in preventing or treating various 
diseases, and have been classified as “Functional”. A 
growing number of these products can be used in 
diabetics, especially in DM2, to regulate glycemic con-
trol60,61. Liquid or solid products for mass consumption7, 
and even novel sweeteners have been studied recent-
ly62. One of them is the natural isomaltulose disac-
charide which can be produced commercially from 
sucrose (beet sugar) on an industrial scale, used in 
various food and beverage, as well as in special nutri-
tional foods and enteral formulas as a food ingredient 
and alternative sugar60,61,63. The applicability of the GI in 
the nutritional label of foodstuffs is currently a contro-
versial premise, groups of authors debate whether it is 
really favorable8 or not to include this indicator in the 
food labeling. In this regard, an article commented that 
the contrary position of Health Canada (HC), is scien-
tifically invalid. HC concluded that the GI has poor 
accuracy for labeling based on incorrect application of 
the standard deviation.
However, the GI methodology is sufficiently accurate to 
distinguish, with high probability, low GI (≤55) or high 
GI (≥70) foods and to approve the procedure required 
by the Canadian Agency’s Nutrition Compliance Test In-
spection of Food2.
Until 2013, Canadian consumers could only access 
to unregulated and misleading GI information. Well-
designed guidelines for the labeling of this indicator 
would provide consumers with accurate information and 
help them choose healthier foods2. If this information 
were to be extended in most food-producing countries, 
a great alternative could be generated in food education 
at large scale.
New perspectives of ig and physical activity
Several studies have evaluated the usefulness of GI in 
exercise on different metabolic markers64,65. GI man-
agement has been reviewed to improve the first and 
second phases of glycogen recovery, glycogen loading 
and metabolism during exercise, including the control 
of rebound hypoglycemia as well as the stimulation of 
lipid oxidation44, confirming that it may influence adipo-
cyte lipolysis, plasma free fatty acid levels and CHO 
oxidation rates. However, at functional level, the results 
have been inconsistent, with evidence of better exer-
cise performance in some studies, but not in others66. 
A meta-analysis of 15 cross-over and randomized trials 
compared the effect of carbohydrate pre-exercise 
meals of low glycemic (LGI) and high glycemic index 
(HGI) on subsequent exercise performance in healthy 
subjects; basing the theory that resistance during ex-
ercise post LGI meal is superior67. There is currently 
no consensus as to whether CHO consumption of 
different GI improves performance68. There is evidence 
that increased muscle glycogen resynthesis demands 
food with CHO  of HGI. However, recent investi-
gations indicate the interaction between CHO, LGI 
and fat oxidation68. In another study with 32 men, who 
followed 1 week of controlled overeating, 3 weeks of 
calorie restriction, and 2 weeks of hypercaloric feed-
back from low v/s high GI; the adaptation of fasting 
macronutrient oxidation and the ability to suppress 
fat oxidation during an oral glucose tolerance test 
were measured, concluding that both the high GI as 
well as the high CHO content affect the oxidation of 
the substrate and, therefore, allow the recovery of body 
weight in healthy men; Arguing in favor of a lower GL 
diet for maintenance of post-weight loss69. Actually, 
this indicator has been useful in evaluating different 
commercial products, such as sports drinks on the 
use of metabolic substrates in the postprandial state 
and their relationship with performance and resistance 
during exercise70. In addition, few studies were made 
on athletes with diagnosis of DM1 and DM2 in relation 
to the GI. For DM1, exercise can cause hypoglycae-
mia. To avoid it, a carbohydrate-rich meal should be 
eaten 1 to 3 hours before exercise with a reduced 
insulin dose.
During the activity, at least 40 g of glucose per hour 
should be ingested and should be increased if the in-
sulin dose is not reduced. After exercise, it is im-
portant to rebuild glycogen stores to reduce the risk of 
hypoglycemia. Despite these difficulties, exercise is 
recommended in DM1 and high competition exer-
cise is, also, possible. Improved insulin sensitiv-
ity, reduced body weight and cardiorespiratory effects 
are evident in DM271. Carbohydrates should only be 
given to prevent hypoglycaemia71.
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Utility of the glycemic index in health programs
There are several studies in the management of weight 
and glycemic profile 72 through specific interventions to-
wards the quality of CHO in the diet. Start Start is a 
randomized controlled trial that assigns overweight and 
DM2 patients into two groups: 1) medication manage-
ment and self-care counseling; 2) low CHO loading with 
pharmacotherapy. It is hypothesized that the last one 
will improve the glycemic profile, reduce hypoglyce-
mia, diabetes medications use and weight in relation 
to medication and self-care counseling, regarding the 
standard management73. In another randomized con-
trolled trial of 162 diabetics, was determined the long-
term effects of a program with changes in the quantity 
or source of CHO on life quality, symptoms and dietary 
satisfaction in patients with DM2; assigned to diets 
differently distributed, high content of carbohydrate/
high-glycemic-index (HGI) diets, high-carbohydrate/
low-glycemic-index diets, or lower-carbohydrate/high- 
monounsaturated-fat for 1 year. HbA1c levels had less 
increment in those patients who gained less weight, 
had less increased appetite and were more satisfied 
from eating. Although overall dietary satisfaction was 
higher on 40% of carbohydrate diets than on the 50% 
of carbohydrate diets, LGI diet was no less satisfying 
than HGI diet74 The DEDICA clinical trial in Italy will 
evaluate the combined effect of a low GI diet, moder-
ate physical activity and vitamin D supplementation on 
breast cancer recurrence in a mediterranean lifestyle in 
506 women for 1 year followed by 33 months75, accord-
ing to their authors, this novel intervention program 
promises to reduce the rate of recurrence of this type 
of pathologies. It is important to consider the effect of 
physical activity on health, as it is one of the protec-
tive factors against the development of obesity, thus 
justifying the generation of intervention programs that 
allow compliance of physical activity recommendations 
according to the target population, which ideally should 
begin in childhood in order to avoid the development 
of pathologies associated with overweight in adult life76. 
Likewise, in specific pathologies such as gestational 
diabetes, moderate physical activity was also directly 
correlated with the decrease in the risk of suffering it, 
as was demonstrated in a cross-sectional study in 579 
pregnant women in Colombia77. Finally, Studies of mul-
tidisciplinary programs, such as Star Star73 and DEDI-
CA75 allows to clarify the current relevance used for 
this indicator in the multidisciplinary health programs, 
specifically focused on bio-medical and nutritional 
care directed to different study groups.
iven the controversy that GI produces, 
especially on methodological aspects, 
the last consensus of experts on this 
topic, concluded that most of the current criticisms are 
not valid, but reflect a failure of the knowledge ex-
pansion. Certain global associations have included this 
indicator in their guidelines, endorsing it as an impor-
tant dietary tool. There is strong evidence suggest-
ing the potential relevance of GI as a new risk marker 
for various pathologies; not only in the different types 
of diabetes, but also in certain heart diseases, 9 types 
of neoplasias and in weight control; recently associat-
ing it with other diseases such as epilepsy, menopause 
and depression. Some of the new perspectives on the 
applicability of this indicator focus on the dietary inter-
vention in athletes to improve resistance in training. Fu-
ture research might relate it to diabetic athletes to avoid 
rebound hypoglycemia during high-competitive sports. 
Another approach considers it a panacea for the food 
industry, especially for functional foods and a novel sys-
tem for various multidisciplinary health programs.
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